Final Programme - iuphar

FC11 G protein-coupled 7TM receptors:
From molecular to physiological function
Wed 068 Role of nitric oxide/cyclic GMP and cyclic AMP in the β-adrenoceptor vasorelaxant response
Maria Dolores Ivorra, (Spain), N Flacco, S Estrada, M Perez-Aso, P D'Ocon
Wed 069 5-HT2C receptor signal peptide
Jan Anker Jahnsen, (Norway), S Uhlen
Wed 070 The angiotensin II type 1 receptor regulates microRNA expression by Gq and Erk1/2 dependent
mechanisms
Pia Jeppesen, (Denmark), GL Christensen, M Schneider, Y Nossent, HB Jensen, DC Andersen,
S Gammeltoft, JL Hansen, SP Sheikh
Wed 071 Inhibition of dopamine and noradrenaline transporters (DAT & NET) and monoamine oxidase (MAO) in
the prefrontal cortex of COMT knock-out mice
Mikko Käenmäki, (Finland), C Amberg, PT Männistö
Wed 072 Evidence for functional heteromerization between melatonin MT1 and MT2 receptors and serotonin
5-HT2C receptors
Maud Kamal, (France), J-L Guillaume, A Daulat, P Chen, C Mannoury La Cour, MJ Millan, L Vincent, O
Nosjean, JA Boutin, M Spedding, P Delagrange, R Jockers
Wed 073 Regulation of GPR55 by the G protein coupled receptor associated sorting proteins
Julia Kargl, (Austria), N Balenga, L Martini, J Whistler, M Waldhoer
Wed 074 Two distinct pathways, PKA and TrkA, mediate activation of CREB during α2-AR induced neuronal
differentiation
G Karkoulias, P Papathanasopoulos, Christodoulos Flordellis, (Greece)
Wed 075 Apelin is a crucial factor for hypoxia-induced retinal angiogenesis
Atsushi Kasai, (Japan), Y Ishimaru, T Kinjo, Y Yoshioka, A Yamamuro, N Shintani, A Baba, S Maeda
Wed 076 Characterization of a sphingosine 1-phosphate receptor antagonist prodrug
Perry Kennedy, (USA), R Zhu, J Tomsig, T Huang, T Mathews, T Macdonald, K Lynch
Wed 077 The GABAB dimers of heterodimers: a way to increase the functional complexity?
Julie Kniazeff, (France), L Comps-Agrar, D Maurel, E Trinquet, J-P Pin
Wed 078 Physiological significance of extracellular ATP in HaCaT keratinocytes
Daisaku Kobayashi, (Japan), S Ohkubo, N Nakahata
Wed 079 Enhanced BRET technology for the monitoring of agonist-induced and agonist-independent interactions
between GPCRs and β-arrestins
Martina Kocan, (Australia), HB See, NG Sampaio, BJ Feldman, KA Eidne, KDG Pfleger
Wed 080 Ligand-directed signalling at the relaxin family peptide receptor 3 (RXFP3)
Martina Kocan, (Australia), ET van der Westhuizen, MA Hossain, JD Wade, RJ Summers
Wed 081 MTα is a selective α2B-adrenoceptor antagonist
Katja Koivula, (Finland), S Rondinelli, J Näsman
Wed 082 The effects of naturally occurring single nucleotide polymorphisms (SNPs) at the glucagon-like peptide
1 receptor (GLP-1R)
Cassandra Koole, (Australia), J Simms, D Wootten, A Christopoulos, PM Sexton
Wed 083 Possible regulation of GABAB receptors expression by phosphatases
Akira Koutani, (Japan), H Niihara, N Kuramoto, K Ogita
250 Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area